Hemogenyx Pharmaceuticals PLC (HEMO) — Free Cash Flow Generation Index

Latest as of June 2017: 0.53x

Hemogenyx Pharmaceuticals PLC (HEMO) has a Free Cash Flow Generation Index of 0.53x as of June 2017. Free cash flow of GBX12.24 represents 1% of operating cash flow (GBX23.26). Read HEMO liabilities breakdown for a breakdown of total debt and financial obligations.

FCF Generation Index

0.53x

Free Cash Flow / Operating CF

Free Cash Flow

GBX12.24

GBX

Operating Cash Flow

GBX23.26

GBX

Capital Expenditures

GBX11.02

GBX

Hemogenyx Pharmaceuticals PLC Free Cash Flow Generation Index (2015–2015)

Historical FCF Generation Index trend for Hemogenyx Pharmaceuticals PLC across 1 annual periods. Explore Hemogenyx Pharmaceuticals PLC capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Hemogenyx Pharmaceuticals PLC (2015–2015)

Year-by-year Free Cash Flow Generation Index for Hemogenyx Pharmaceuticals PLC. For the full company profile including market capitalisation, see Hemogenyx Pharmaceuticals PLC (HEMO) total market value.

Year	FCG Index	Free Cash Flow (GBX)	Operating CF	Capital Expenditures	YoY Change
2015	1.00x	GBX79.71	GBX79.71	GBX0.00	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).